Repligen Corp Third Quarter Earnings Sneak Peek

Repligen Corporation (NASDAQ:RGEN) will unveil its latest earnings on Thursday, November 8, 2012. Repligen is a biopharmaceutical company focused primarily on the development of novel therapeutics for radiology and neuropsychiatry.

Repligen Corporation Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 2 cents per share, no change from the company’s actual earnings in the year-ago quarter. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month.

Past Earnings Performance: The company will look to avoid falling below estimates this quarter after beating forecasts last quarter. Last quarter, it beat expectations as it reported net income of 5 cents versus a mean estimate of profit of one cent.

Earnings season is back and more important than ever. Get our newest CHEAT SHEET stock picks now

A Look Back: In the second quarter, the company swung to a profit of $1.6 million (5 cents a share) from a loss of $55,597 (0 cents) a year earlier, beating analyst estimates. Revenue rose more than twofold to $15.5 million from $7.7 million.

Stock Price Performance: Between October 5, 2012 and November 2, 2012, the stock price dropped 90 cents (-15.2%), from $5.92 to $5.02. The stock price saw one of its best stretches over the last year between August 15, 2012 and August 27, 2012, when shares rose for nine straight days, increasing 19.1% (+90 cents) over that span. It saw one of its worst periods between October 3, 2012 and October 10, 2012 when shares fell for six straight days, dropping 10.7% (-66 cents) over that span.

Balance Sheet Analysis: The company’s current ratio of assets to liabilities came in at 5.38 last quarter. Having a ratio above 2:1 is usually considered a good indicator of a company’s liquidity and ability to meet creditor demands. The company regressed in this liquidity measure from 5.77 in the first quarter to the last quarter driven in part by an increase in liabilities. Current liabilities increased 10.7% to $9.7 million while assets rose 3.2% to $52.4 million.

Key Stats:

On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 18.1% in the second quarter, 1.4% in the fourth quarter of the last fiscal year and more than twofold in the first quarter before increasing again in the second quarter.

The company’s gross margin shrank by 25.1 percentage points in the in the second quarter. Revenue rose 102.8% while cost of sales rose 300.4% to $7.9 million from a year earlier.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute — click here and get our CHEAT SHEET stock picks now.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

Is AT&T’s Stock a Buy as iPhone Sales Soar?

Is LinkedIn Still a Wall Street Darling?

Should Netflix Shareholders Hope for a Buyout?